Skip to content
Pharma Supply Chain Faces Challenges in AI Adoption and Visibility

Pharma Supply Chain Faces Challenges in AI Adoption and Visibility

First seen 8 Oct 2026, 20:33 UTC • •
API

Article Content

Browse articles
ThreatCluster AI
ThreatCluster •October 9, 2026 at 19:35 UTC
  • •Pharmaceutical companies struggle with AI adoption due to poor data organization.
  • •Mark Talens emphasizes the need for contextualization before AI implementation.
  • •Fragmented visibility in supply chains leads to ineffective decision-making.

At LogiPharma USA 2026, Mark Talens of PAXAFE highlighted significant gaps in pharmaceutical supply chains, particularly regarding data organization and the effective use of AI tools. He noted that many companies are deploying AI without first preparing their data infrastructure, leading to disillusionment with the technology. Talens emphasized the importance of contextualizing data before applying AI, warning that fragmented visibility across supply chain functions hampers decision-making. He advocated for a structured approach to data management, suggesting that organizations should focus on understanding their data before integrating advanced tools. The discussion reflects ongoing challenges in the pharmaceutical industry regarding supply chain efficiency and the integration of modern technologies.

Start a free Starter trial for enhanced analysis

Ask AI about this cluster

Updated 16d ago How this analysis works

Timeline

2026-10-07
Mark Talens speaks at LogiPharma USA 2026
Talens discusses the importance of data organization and contextualization for effective AI use in supply chains.
Pharmexec
2026-10-08
Talens highlights shared visibility benefits
In a panel discussion, Talens explains how shared visibility can enhance decision-making in pharma supply chains.
Pharmaceuticalcommerce

More articles in this cluster (4)

Following this threat?

Track Merck in your own feed — you're alerted when they show up in new reporting, leak sites or exploitation.

Free account · no card needed

Extracted Entities (3)

1 / 2

Common questions

What are the key challenges in pharma supply chains?
Key challenges include poor data organization, lack of cross-functional expertise, and fragmented visibility.
How should companies prepare for AI integration?
Companies should first organize their data and establish clear rule sets before implementing AI tools.
What is the impact of fragmented visibility?
Fragmented visibility can lead to uncoordinated responses and ineffective decision-making in supply chains.